American CryoStem Completes Cell Processing for Clinical Study

RED BANK, NJ–(Marketwire – Feb 7, 2012) – American CryoStem Corporation (OTCQB: CRYO) announced today that it has completed providing stem cell processing services for Personal Cell Sciences Corp., a cutting edge manufacturer of anti-aging skin care products.

The study involves researching the regenerative function of a conditioned medium obtained from each participant’s adipose (fat tissue) derived mesenchymal stem cells and their ability to promote the production or secretion of collagen, elastin and fibronectin related to skin wound healing.

John Arnone, CEO of American CryoStem and Founder of Personal Cell Sciences, commented, “CRYO’s patented tissue culture media and its proprietary, aseptic adipose tissue processing methodology allows, as an added benefit for PCS customers to store a clinical grade sample of their own stem cells for future use in regenerative medicine. We are pleased to provide comprehensive Bio-Insurance storage solutions at our clinical facility.”

The adipose tissue samples were acquired utilizing a mini-liposuction procedure. A total of sixty milliliters (approximately 2 fluid ounces) of adipose tissue was collected in the physician’s office and sent to CRYO’s laboratory for processing. Once processed, the resulting stromal vascular fraction (SVF) was forwarded to the Personal Cell Sciences laboratory for proprietary formulation for patient specific products.

“We are very excited to announce our service agreement and participation in this clinical study for Personal Cell Sciences. This contractual manufacturing agreement reinforces our capabilities to provide CRYO’s exceptional clinical processing for relevant adult stem cell related products,” said Anthony Dudzinski, COO of American CryoStem. “We look forward to our continued business relationship with PCS and expanding these services to other developers to speed their product’s time to market.”

About American CryoStem: American CryoStem Corporation (OTCQB: CRYO) markets clinical processing products and services for Adipose (fat) Tissue and Adipose Derived Adult Stem Cells. CRYO’s clinical processing and preservation platform supports the science and applications being discovered globally by providing the highest quality, clinically processed cells and assuring their sterility, viability and growth cap abilities, while at the same time developing cutting edge application, therapies and laboratory products and services for consumers and physicians.

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the Company is detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission.

For More Information, contact:
Investor Relations
American CryoStem Corporation
188 East Bergen Place, Suite 204
Red Bank, NJ 07701
Phone:732-747-1007
www.americancryostem.com

Does fat flow from the fountain of youth?

Juan Ponce de Leon is best known for his search for the fountain of youth. Though this story is probably more fiction than fact, and was attributed to him only after his death, the legend of the fountain of youth and the quest for it have persisted since the 16th century. It has proven to be as elusive as the Holy Grail.

I hear a lot of baby boomers (of which I am one) talk about aging and the quest to maintain their youthful look, mind and health. If only there was a magic elixir for the myriad problems we face in our advancing age. Well, perhaps there is something that can turn back the hands of time to some extent, a little bit of the fountain of youth if you will.

Adipose tissue has been found to be an easily accessible, abundant source of adult stem cells. These stem cells can be used to treat a broad range of medical and cosmetic conditions. If you look at our Resource Library, you’ll see a sampling of the potential applications of adipose derived stem cells, from growing new bone to aiding reconstructive procedures to mitigating the symptoms of multiple sclerosis. And, yes, adipose derived stem cells can help us look youthful too. You can have lipofilling and lipostructuring performed anywhere on your body. Isn’t this a dream come true? Take your fat from a place you don’t want it and put it somewhere you do! Who of us wouldn’t like to remove a few pounds of avoir du pois and apply it elsewhere?

All joking aside, the potential future medical applications for adipose derived stem cells are profound, and they are not that far off. Now is the dawn of the era of regenerative and personalized medicine. Most countries outside of the United States are already using adult stem cells to treat patients with myocardial infarctions, fistulizing Crohn’s disease, and to grow organs. Medical tourism, traveling to other countries to take advantage of treatments not yet routinely available in the United States, has become a booming industry in part because of regenerative and personalized medicine. It is only a matter of time before these therapies become available in the U.S.

So this brings to mind a question. What can I do now to prepare? Speaking for myself, I already have an answer. I will store my adult stem cells in the hope of using them later in the event of a medical ailment, or, in a more vain moment, when I want to reverse the visible “hands of time” with a cosmetic treatment. Not only will I store my own adult stem cells, but I will encourage my children to store theirs as well. After all, that one umbilical cord blood sample I keep may not be useful for all three of them, so why leave anything to chance? It is a bio-insurance that will give me some peace of mind as a mother. It is also a gift I will be giving to family and loved ones. What about you?

Angela M. Miele, DPM
Medical Science Liaison
American CryoStem